Sarcopenia in chronic kidney disease: from bench to bedside
Da Woon Kim, Sang Heon Song
Korean J Intern Med. 2023;38(3):303-321. Published online 2023 Apr 20 DOI: https://doi.org/10.3904/kjim.2022.338
Citations to this article as recorded by 
Hypoxia‐inducible factor prolyl hydroxylase domain inhibitors may mitigate loss of skeletal muscle mass in haemodialysis patients
Hiroko Hashimoto, Shintaro Mandai, Satomi Shikuma, Mai Kimura, Hayato Toma, Yuki Sakaguchi, Moe Kimura, Jun Ota, Yoshihiko Chiba, Keigo Sakai, Susumu Horiuchi, Susumu Adachi, Shinichi Uchida
JCSM Communications.2024;[Epub] CrossRef
The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney Disease
Kuo-Chin Hung, Wei-Cheng Yao, Yi-Lien Liu, Hung-Jen Yang, Min-Tser Liao, Keong Chong, Ching-Hsiu Peng, Kuo-Cheng Lu
Biomedicines.2023; 11(7): 2076. CrossRef
Organ Crosstalk Contributes to Muscle Wasting in Chronic Kidney Disease
Xiaonan H. Wang, S. Russ Price
Seminars in Nephrology.2023; 43(2): 151409. CrossRef